Vanguard Group’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $40.9M | Sell |
32,457,788
-5,078,109
| -14% | -$7.07M | ﹤0.01% | 2276 |
|
|
2025
Q3 | $58.2M | Sell |
37,535,897
-702,817
| -2% | -$965K | ﹤0.01% | 2083 |
|
|
2025
Q2 | $50.5M | Buy |
38,238,714
+8,738,643
| +30% | +$11.9M | ﹤0.01% | 2114 |
|
|
2025
Q1 | $49M | Buy |
29,500,071
+293,740
| +1% | +$484K | ﹤0.01% | 2100 |
|
|
2024
Q4 | $42.9M | Sell |
29,206,331
-11,819
| -0% | -$18.1K | ﹤0.01% | 2231 |
|
|
2024
Q3 | $43.5M | Buy |
29,218,150
+976,017
| +3% | +$1.45M | ﹤0.01% | 2239 |
|
|
2024
Q2 | $35.3M | Sell |
28,242,133
-1,259,098
| -4% | -$1.63M | ﹤0.01% | 2288 |
|
|
2024
Q1 | $35.4M | Sell |
29,501,231
-10,250,062
| -26% | -$10.3M | ﹤0.01% | 2320 |
|
|
2023
Q4 | $60M | Buy |
39,751,293
+428,520
| +1% | +$619K | ﹤0.01% | 2110 |
|
|
2023
Q3 | $62.9M | Buy |
39,322,773
+11,989
| +0% | +$21.8K | ﹤0.01% | 2025 |
|
|
2023
Q2 | $85.3M | Sell |
39,310,784
-2,244,148
| -5% | -$3.51M | ﹤0.01% | 1938 |
|
|
2023
Q1 | $60.7M | Buy |
41,554,932
+434,438
| +1% | +$559K | ﹤0.01% | 2084 |
|
|
2022
Q4 | $51.4M | Buy |
41,120,494
+835,721
| +2% | +$1.32M | ﹤0.01% | 2174 |
|
|
2022
Q3 | $76.1M | Sell |
40,284,773
-2,296,471
| -5% | -$5.43M | ﹤0.01% | 1960 |
|
|
2022
Q2 | $108M | Buy |
42,581,244
+6,509,113
| +18% | +$19M | ﹤0.01% | 1774 |
|
|
2022
Q1 | $124M | Buy |
36,072,131
+346,707
| +1% | +$1.22M | ﹤0.01% | 1825 |
|
|
2021
Q4 | $172M | Buy |
35,725,424
+259,540
| +0.7% | +$1.05M | ﹤0.01% | 1697 |
|
|
2021
Q3 | $129M | Sell |
35,465,884
-266,596
| -0.7% | -$992K | ﹤0.01% | 1840 |
|
|
2021
Q2 | $145M | Buy |
35,732,480
+247,389
| +0.7% | +$970K | ﹤0.01% | 1805 |
|
|
2021
Q1 | $152M | Buy |
35,485,091
+1,034,937
| +3% | +$4.94M | ﹤0.01% | 1725 |
|
|
2020
Q4 | $136M | Sell |
34,450,154
-1,408,746
| -4% | -$5.88M | ﹤0.01% | 1672 |
|
|
2020
Q3 | $132M | Sell |
35,858,900
-1,365,860
| -4% | -$5.77M | ﹤0.01% | 1535 |
|
|
2020
Q2 | $127M | Sell |
37,224,760
-147,062
| -0.4% | -$329K | ﹤0.01% | 1554 |
|
|
2020
Q1 | $50.1M | Sell |
37,371,822
-172,828
| -0.5% | -$271K | ﹤0.01% | 1868 |
|
|
2019
Q4 | $55.2M | Buy |
37,544,650
+3,862,958
| +11% | +$6.47M | ﹤0.01% | 2060 |
|
|
2019
Q3 | $70.4M | Buy |
33,681,692
+3,214,149
| +11% | +$6.57M | ﹤0.01% | 1914 |
|
|
2019
Q2 | $74.3M | Buy |
30,467,543
+812,237
| +3% | +$1.77M | ﹤0.01% | 1902 |
|
|
2019
Q1 | $77.4M | Buy |
29,655,306
+1,273,653
| +4% | +$3.86M | ﹤0.01% | 1869 |
|
|
2018
Q4 | $85.4M | Sell |
28,381,653
-1,279,097
| -4% | -$4.34M | ﹤0.01% | 1769 |
|
|
2018
Q3 | $103M | Buy |
29,660,750
+614,442
| +2% | +$3.26M | ﹤0.01% | 1791 |
|
|
2018
Q2 | $137M | Buy |
29,046,308
+1,207,884
| +4% | +$4.58M | 0.01% | 1609 |
|
|
2018
Q1 | $88.2M | Buy |
27,838,424
+164,289
| +0.6% | +$662K | ﹤0.01% | 1782 |
|
|
2017
Q4 | $136M | Buy |
27,674,135
+531,373
| +2% | +$3.08M | 0.01% | 1550 |
|
|
2017
Q3 | $186M | Buy |
27,142,762
+524,004
| +2% | +$3.3M | 0.01% | 1317 |
|
|
2017
Q2 | $175M | Buy |
26,618,758
+296,757
| +1% | +$2.08M | 0.01% | 1311 |
|
|
2017
Q1 | $211M | Buy |
26,322,001
+1,112,843
| +4% | +$9.37M | 0.01% | 1189 |
|
|
2016
Q4 | $234M | Buy |
25,209,158
+701,143
| +3% | +$7.25M | 0.01% | 1072 |
|
|
2016
Q3 | $260M | Buy |
24,508,015
+1,406,538
| +6% | +$14M | 0.02% | 940 |
|
|
2016
Q2 | $216M | Buy |
23,101,477
+161,981
| +0.7% | +$1.64M | 0.01% | 1006 |
|
|
2016
Q1 | $238M | Buy |
22,939,496
+1,033,398
| +5% | +$9.44M | 0.02% | 929 |
|
|
2015
Q4 | $220M | Buy |
21,906,098
+619,997
| +3% | +$6.21M | 0.01% | 950 |
|
|
2015
Q3 | $179M | Buy |
21,286,101
+6,127,748
| +40% | +$81.1M | 0.01% | 1061 |
|
|
2015
Q2 | $244M | Buy |
15,158,353
+1,200,954
| +9% | +$18.7M | 0.02% | 935 |
|
|
2015
Q1 | $198M | Sell |
13,957,399
-481,586
| -3% | -$6.27M | 0.01% | 1052 |
|
|
2014
Q4 | $144M | Buy |
14,438,985
+1,594,051
| +12% | +$13.6M | 0.01% | 1172 |
|
|
2014
Q3 | $109M | Buy |
12,844,934
+171,624
| +1% | +$1.51M | 0.01% | 1286 |
|
|
2014
Q2 | $112M | Sell |
12,673,310
-46,927
| -0.4% | -$410K | 0.01% | 1319 |
|
|
2014
Q1 | $119M | Buy |
12,720,237
+549,210
| +5% | +$4.81M | 0.01% | 1238 |
|
|
2013
Q4 | $103M | Buy |
12,171,027
+626,135
| +5% | +$6.33M | 0.01% | 1300 |
|
|
2013
Q3 | $102M | Buy |
11,544,892
+3,247,748
| +39% | +$26.1M | 0.01% | 1230 |
|
|
2013
Q2 | $58.9M | Buy |
+8,297,144
| New | +$57.3M | 0.01% | 1518 |
|
Other funds holding OPK
RCMNY
WCM
Vanguard Group's OPK Position: Q4 2025 in Review
Vanguard Group reduced its Opko Health (OPK) stake by 14% in Q4 2025, selling an estimated $7.07M and leaving 32,457,788 shares worth $40.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2276.
Vanguard Group first reported a position in OPK in Q2 2013 and has held it in 51 quarters since. The position peaked at $260M in Q3 2016. 220 funds tracked by Wall St. Rank hold OPK as of Q4 2025.
- Vanguard Group held 32,457,788 shares of Opko Health worth $40.9M as of Q4 2025.
- Vanguard Group sold 5,078,109 Opko Health shares in Q4 2025, an estimated $7.07M.
- Opko Health made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2276 holding.
- Vanguard Group first reported a position in Opko Health in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Opko Health position peaked at $260M in Q3 2016.
- 220 funds tracked by Wall St. Rank held Opko Health as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.